- Home
- CREX vs ICCM Comparison
CREX vs ICCM Comparison
Compare CREX & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CREX
- ICCM
- Stock Information
- Founded
- CREX N/A
- ICCM 2006
- Country
- CREX United States
- ICCM Israel
- Employees
- CREX N/A
- ICCM N/A
- Industry
- CREX EDP Services
- ICCM
- Sector
- CREX Technology
- ICCM
- Exchange
- CREX Nasdaq
- ICCM Nasdaq
- Market Cap
- CREX 44.8M
- ICCM 45.5M
- IPO Year
- CREX N/A
- ICCM N/A
- Fundamental
- Price
- CREX $2.95
- ICCM $1.12
- Analyst Decision
- CREX Strong Buy
- ICCM Strong Buy
- Analyst Count
- CREX 2
- ICCM 2
- Target Price
- CREX $8.00
- ICCM $2.70
- AVG Volume (30 Days)
- CREX 65.6K
- ICCM 646.4K
- Earning Date
- CREX 11-13-2024
- ICCM 11-26-2024
- Dividend Yield
- CREX N/A
- ICCM N/A
- EPS Growth
- CREX N/A
- ICCM N/A
- EPS
- CREX 0.07
- ICCM N/A
- Revenue
- CREX $54,300,000.00
- ICCM $3,671,000.00
- Revenue This Year
- CREX $22.92
- ICCM $18.61
- Revenue Next Year
- CREX $18.39
- ICCM $54.91
- P/E Ratio
- CREX $41.26
- ICCM N/A
- Revenue Growth
- CREX 31.80
- ICCM 26.02
- 52 Week Low
- CREX $2.09
- ICCM $0.48
- 52 Week High
- CREX $5.20
- ICCM $1.57
- Technical
- Relative Strength Index (RSI)
- CREX 42.78
- ICCM 75.27
- Support Level
- CREX $2.76
- ICCM $0.79
- Resistance Level
- CREX $3.10
- ICCM $1.19
- Average True Range (ATR)
- CREX 0.23
- ICCM 0.08
- MACD
- CREX 0.04
- ICCM 0.03
- Stochastic Oscillator
- CREX 66.13
- ICCM 84.44
About CREX Creative Realities Inc.
Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to global retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.